Kayne Anderson Rudnick Investment Management LLC decreased its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 97,962 shares of the company's stock after selling 6,479 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC's holdings in Procter & Gamble were worth $16,695,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the stock. Nuveen LLC purchased a new position in shares of Procter & Gamble during the 1st quarter valued at approximately $1,954,941,000. GAMMA Investing LLC grew its position in Procter & Gamble by 20,758.5% during the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after buying an additional 7,913,335 shares during the period. Northern Trust Corp increased its holdings in Procter & Gamble by 10.1% in the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock valued at $4,928,107,000 after buying an additional 2,703,757 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Finally, Invesco Ltd. raised its position in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Trading Up 0.6%
Procter & Gamble stock traded up $0.99 during mid-day trading on Wednesday, hitting $156.96. The company's stock had a trading volume of 4,548,118 shares, compared to its average volume of 7,181,753. The stock's fifty day moving average is $156.63 and its two-hundred day moving average is $162.72. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $367.67 billion, a PE ratio of 24.11, a price-to-earnings-growth ratio of 4.12 and a beta of 0.37. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 64.98%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on PG shares. Redburn Partners set a $161.00 target price on Procter & Gamble in a research report on Thursday, May 1st. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. Piper Sandler boosted their price objective on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research report on Monday, May 5th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Barclays set a $164.00 price target on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $175.94.
Get Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, CAO Matthew W. Janzaruk sold 319 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $50,169.13. Following the completion of the sale, the chief accounting officer owned 1,704 shares in the company, valued at approximately $267,988.08. This trade represents a 15.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 119,181 shares of company stock valued at $18,761,172. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report